HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 71/6/2037    most recent biolreprod.104.032870v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by D'Cruz, O. J. Articles by Uckun, F. M. Search for Related Content PubMed PubMed Citation Articles by D'Cruz, O. J. Articles by Uckun, F. M. Agricola Articles by D'Cruz, O. J. Articles by Uckun, F. M.

PHI-443: A Novel Noncontraceptive Broad-Spectrum Anti-Human Immunodeficiency Virus Microbicide¹

Drug Discovery Program, Department of Reproductive Biology,³ Pharmaceutical Sciences,⁴ Virology,⁵ Parker Hughes Institute, St. Paul, Minnesota 55113 Paradigm Pharmaceuticals, LLC,⁶ St. Paul, Minnesota 55113

PHI-443 (N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea) is a rationally designed novel thiophene thiourea nonnucleoside reverse transcriptase inhibitor (NNRTI) with potent anti-HIV activity against the wild-type and drug-resistant primary clinical human immunodeficiency virus (HIV-1) isolates. This study examined the potential utility of PHI-443 as a nonspermicidal microbicide for prevention of sexual transmission of HIV. Our goal in this study was to test the effects of PHI-443 on in vivo sperm functions under conditions shown to inactivate viruses in human cells. PHI-443 completely prevented the vaginal transmission of a genotypically and phenotypically drug-resistant HIV-1 isolate in the humanized severe combined immunodeficient (Hu-SCID) mouse model of sexually transmitted AIDS. Exposure of human sperm to PHI-443 at doses 30 000 times higher than those that yield effective concentrations against the AIDS virus had no adverse effect on sperm motility, kinematics, cervical mucus penetrability, or the viability of vaginal and cervical epithelial cells. Exposure of rabbit semen to PHI-443 either ex vivo or in vivo had no adverse impact on in vivo fertilizing ability in the rabbit model. Reproductive indices (i.e., pregnancy rate, embryo implantation, and preimplantation losses) were not affected by pretreatment of rabbit semen with PHI-443. Likewise, intravaginal application of 2% PHI-443 via a self-emulsifying gel at the time of artificial insemination resulted in healthy offspring with no apparent peri- or postnatal repercussions. Repeated intravaginal administration of 0.5%– 2% PHI-443 gel was found to be safe in rabbits and lacked systemic absorption. PHI-443 has clinical potential as a prophylactic broad-spectrum anti-HIV microbicide without contraceptive activity.

¹ Supported in part by National Institute of Health grants HD 37357, HD 42884, HD 42889, HD 43683, and AI 54352 to O.J.D.

² Correspondence: Osmond J. D'Cruz, Parker Hughes Institute, 2657 Patton Road, St. Paul, MN 55113. FAX: 651 628 9891; odcruz{at}ih.org

This article has been cited by other articles:

				O. J. D'Cruz and F. M. Uckun Dawn of non-nucleoside inhibitor-based anti-HIV microbicides J. Antimicrob. Chemother., March 1, 2006; 57(3): 411 - 423. [Abstract] [Full Text] [PDF]

				O. J. D'Cruz and F. M. Uckun Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide Mol. Hum. Reprod., October 1, 2005; 11(10): 767 - 777. [Abstract] [Full Text] [PDF]

				O. J. D'cruz, D. Erbeck, and F. M. Uckun A Study of the Potential of the Pig as a Model for the Vaginal Irritancy of Benzalkonium Chloride in Comparison to the Nonirritant Microbicide PHI-443 and the Spermicide Vanadocene Dithiocarbamate Toxicol Pathol, June 1, 2005; 33(4): 465 - 476. [Abstract] [Full Text] [PDF]